FOR UK HEALTHCARE PROFESSIONALS ONLY

Cost Saving

By prescribing Sevodyne® by brand you could save 69% on your
current buprenorphine 7-day transdermal patches prescribing costs.1**

By prescribing Sevodyne by brand, the average savings for a CCG could still be £58,379 per year,2* providing the NHS with a total potential annual prescribing cost saving of approximately £12.7 million.2*

Sevodyne Cost Calculator

To find out how much you could save by prescribing Sevodyne, please follow the instructions on the Sevodyne calculator:

Button Text

Sevodyne is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • 69% saving on UK Drug Tariffs price for buprenorphine transdermal patches1**
  • Available from mainline wholesalers
  • Pricing not dependent on competitor activity***
  • Price guaranteed***
ProductUK Drug Tariffs price1Sevodyne priceNHS Saving when Sevodyne is Prescribed
Buprenorphine transdermal patch 5 microgram/hr x 4£17.60 £5.53£12.07
Buprenorphine transdermal patch 10 microgram/hr x 4£31.55£9.93£21.62
Buprenorphine transdermal patch 15 microgram/hr x 4£49.15£15.48£33.67
Buprenorphine transdermal patch 20 microgram/hr x 4£57.46£18.09£39.37
*Savings based on market data in reference 2. Savings calculated from 2020 spend of 218 CCGs switching their generic and originator brand 5, 10, 15 and 20mcg buprenorphine transdermal patch prescriptions to Sevodyne. **Based on 69% saving on the cost of buprenorphine transdermal patches in the UK Drug Tariffs. ***No change in price subject to no material change to the products of the UK Drug Tariffs until the 2024 PPRS review.
References: 1) October 2020 UK Drug Tariffs. 2) Insypher Data June 2020 Based on Annual Moving Total (UK)

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.

For further information please call: 01730 231148,
email: customerservices@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Sevodyne, please see the abbreviated prescribing information.

Revision reference – Sevodyne_10_30.10.2020

More products available
in this range:
Click to view their
individual websites